BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35910798)

  • 1. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
    Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
    Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
    Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
    Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
    Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells.
    Sousa-Squiavinato ACM; Arregui Ramos DA; Wagner MS; Tessmann JW; de-Freitas-Junior JCM; Morgado-Díaz JA
    Eur J Pharmacol; 2022 Oct; 933():175253. PubMed ID: 36067803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota.
    Sougiannis AT; VanderVeen BN; Enos RT; Velazquez KT; Bader JE; Carson M; Chatzistamou I; Walla M; Pena MM; Kubinak JL; Nagarkatti M; Carson JA; Murphy EA
    Brain Behav Immun; 2019 Aug; 80():44-55. PubMed ID: 30807838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
    Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
    Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
    Onozawa H; Saito M; Saito K; Kanke Y; Watanabe Y; Hayase S; Sakamoto W; Ishigame T; Momma T; Ohki S; Takenoshita S
    Oncol Rep; 2017 Jan; 37(1):235-240. PubMed ID: 27840982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 1A1 is essential for the microbial metabolite, Urolithin A-mediated protection against colitis.
    Ghosh S; Moorthy B; Haribabu B; Jala VR
    Front Immunol; 2022; 13():1004603. PubMed ID: 36159798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.
    Touil Y; Igoudjil W; Corvaisier M; Dessein AF; Vandomme J; Monté D; Stechly L; Skrypek N; Langlois C; Grard G; Millet G; Leteurtre E; Dumont P; Truant S; Pruvot FR; Hebbar M; Fan F; Ellis LM; Formstecher P; Van Seuningen I; Gespach C; Polakowska R; Huet G
    Clin Cancer Res; 2014 Feb; 20(4):837-46. PubMed ID: 24323901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer.
    Zhao Y; Wang C; Goel A
    Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.
    Gao Z; Li Z; Liu Y; Liu Z
    Mol Genet Genomic Med; 2019 Mar; 7(3):e554. PubMed ID: 30623608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines.
    Plasencia C; Abad A; Martinez-Balibrea E; Taron M
    Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells.
    Gao Q; Li XX; Xu YM; Zhang JZ; Rong SD; Qin YQ; Fang J
    Cancer Lett; 2020 Apr; 476():67-74. PubMed ID: 32061752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
    Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
    Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urolithin A attenuates arsenic-induced gut barrier dysfunction.
    Ghosh S; Banerjee M; Haribabu B; Jala VR
    Arch Toxicol; 2022 Apr; 96(4):987-1007. PubMed ID: 35122514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-Hydroxybutyrate Promotes Proliferation, Migration and Stemness in a Subpopulation of 5FU Treated SW480 Cells: Evidence for Metabolic Plasticity in Colon Cancer.
    Shakery A; Pourvali K; Ghorbani A; Fereidani SS; Zand H
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3287-3294. PubMed ID: 30486639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of 5FU and propolis on AOM/DSS induced colorectal cancer in BALB-c mice.
    Sameni HR; Yosefi S; Alipour M; Pakdel A; Torabizadeh N; Semnani V; Bandegi AR
    Life Sci; 2021 Jul; 276():119390. PubMed ID: 33794252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5‑FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53‑mutated colon cancer cells.
    Akasaka T; Tsujii M; Kondo J; Hayashi Y; Ying J; Lu Y; Kato M; Yamada T; Yamamoto S; Inoue T; Tsujii Y; Maekawa A; Fujinaga T; Shiraishi E; Hiyama S; Inoue T; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Jan; 46(1):63-70. PubMed ID: 25310623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urolithin A Alleviates Colitis in Mice by Improving Gut Microbiota Dysbiosis, Modulating Microbial Tryptophan Metabolism, and Triggering AhR Activation.
    Ma M; Wang Y; Fan S; Huang Y; Su X; Lu C
    J Agric Food Chem; 2023 May; 71(20):7710-7722. PubMed ID: 37167350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.